RT Journal Article
SR Electronic
T1 Knowledge, attitude, practice and fear of COVID-19: A cross-cultural study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.26.20113233
DO 10.1101/2020.05.26.20113233
A1 Ali, Mohammad
A1 Uddin, Zakir
A1 Banik, Palash Chandra
A1 Hegazy, Fatma A.
A1 Zaman, Shamita
A1 Ambia, Abu Saleh Mohammed
A1 Siddique, Md. Kaoser Bin
A1 Islam, Rezoana
A1 Khanam, Fatema
A1 Bahalul, Sayed Mohammad
A1 Sharker, Md Ahiduzzaman
A1 Hossain, F M Akram
A1 Ahsan, Gias U
YR 2020
UL http://medrxiv.org/content/early/2020/05/26/2020.05.26.20113233.abstract
AB Background Knowledge, Attitude and Practice (KAP), and Fear toward COVID-19 are an important issue when designing public health approaches to control the spread of this highly contagious disease like COVID-19 during the global pandemic period. Studies with KAP and fear measures are limited only regional or country level, not yet with global or cross-cultural populations. The study is aimed to measure KAP and fear level towards COVID-19 and explore its cross-cultural variances in knowledge by socio-demographic factors among the general population of 8 different countries over 5 continents.Method A cross-sectional online survey was conducted in April 2020 among 1296 participants using the Google form platform. Considering the social distancing formula and pandemic situation, we collect data using popular social media networks. Univariate and bivariate analyses were used to explore the collected data on KAP, fear, and sociodemographic factors.Result Overall knowledge score was 9.7 (out of 12) and gender differences (female vs male: 9.8 vs 9.5) were significant (p=0.008) in the bivariate analysis. Knowledge score variances found significant in some regions by gender, marital status and education qualification. The highest and lowest mean knowledge scores were recorded in the Middle East (10.0) and Europe (9.3). Despite having a high fear score (22.5 out of 35), 78.35% of respondents were in a positive attitude and 81.7% in good practice level. Fear score rankings: Middle East (1st; 23.8), Europe (2nd; 23.2); Africa (3rd; 22.7); South Asia (4th; 22.1); Oceania (5th; 21.9); and North America (6th; 21.7). We didn’t find a correlation between fear and knowledge.Limitation Due to the nature of the online survey, aged and rural populations are under-representing (e.g. more than half of the responders are 16-29 age group).Conclusion KAP and fear variation exist among geographical regions. Gender, marital status and education qualification are factors in knowledge variances for some regions. KAP and fear measures can assist health education programs considering some sociodemographic factors and regions during an outbreak of highly contagious disease and, which can uplift a positive attitude and good practice.HighlightsCross-cultural KAP and fear toward COVID-19 are evaluatedRespondents from Europe scored less knowledge on COVID 19 but had more good knowledge levelAbout 80% participants had positive attitude and good practice behavior.Interestingly, Participants in Oceania avoided more crowded places whereas, in Europe worn more masks during outing as a measure of preventionParticipants in Middle East had the highest score in fear, and fear was independent of knowledgeCompeting Interest StatementThe authors have declared no competing interest.Clinical TrialNot applicableFunding StatementThe authors have declared that no competing interests exist.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We conducted the study according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects were approved by the Institutional Review Board (IRB) of North South University (NSU-IRB-20-013023). Informed consent was taken using the Google Form platform before participating the online survey. The survey was voluntary, anonymous and confidential.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data sets used and analyzed for this study are available. Please feel free to ask to the corresponding author. We have also provided some supplementary data.